Recent articles

Three organizations—an academic institution, a non-profit and a company—are working to understand the prevalence, outcomes and risk factors for contracting COVID-19. By collecting real world data, this will inform doctors and researchers to understand the additional risks and possible treatments for people with type 1 diabetes (T1D) with the coronavirus pandemic. Two of them are specifically […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.